Montuenga, Luis M.

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Gettinger, S., Choi, J., Hastings, K., Truini, A., Datar, I., Sowell, R., Wurtz, A., Dong, W., Cai, G., Melnick, M. A., et al. (2017) · Cancer Discovery

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 787

Immunocytochemical localization of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in human endocrine pancreas.

Martínez, A., Montuenga, L. M., Springall, D. R., Treston, A., Cuttitta, F., & Polak, J. M. (1993) · Journal of Histochemistry & Cytochemistry

Pancreatic function and diabetesNeuropeptides and Animal Physiology

Cited by 31

Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development

Thunnissen, F. B., Prinsen, C., Hol, B., Van der Drift, M., Vesin, A., Brambilla, C., Montuenga, L., & Field, J. K. (2012) · Lung Cancer

Lung Cancer Treatments and MutationsSmoking Behavior and Cessation

Cited by 19

Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System

Herrera-Campos, A. B., Zamudio-Martinez, E., Delgado-Bellido, D., Fernández-Cortés, M., Montuenga, L. M., Oliver, F. J., & Garcia-Diaz, A. (2022) · Cancers

Cancer, Hypoxia, and MetabolismCancer Immunotherapy and Biomarkers

Cited by 17